$SGMO SANGAMO THERAPEUTICS, INC Insider Trading

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

CIK Number: 0001001233
IRS Number: 680359556
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: SGMO
Company Address: 7000 MARINA BLVD BRISBANE 94005
Former name: SANGAMO BIOSCIENCES INC, date of change: 2000-02-08

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA.

Market Capitalization: $254.24M
Prev close: $3.85
Average Daily Volume: 923,424
Days Low: $3.55
Year Low: $2.65
Year High: $7.60

SANGAMO THERAPEUTICS, INC Insiders Active In Last 3 Months

Name	Position	Total Shares	Current Value ($)	Last 3 Months	Buy / Sell	Last Transaction
Hillan Kenneth	Director	15,000	57,750	shares bought: 15,000 / shares sold: 0	BUY	Sep 11 2020	3 months ago

View all SANGAMO THERAPEUTICS, INC insiders.

SANGAMO THERAPEUTICS, INC Latest Insider Transactions

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 11 2020	SGMO	SANGAMO THERAPEUTI ...	Hillan Kenneth J.	Director	Option Exercise	A	10.43	30,000	312,900	30,000
Sep 11 2020	SGMO	SANGAMO THERAPEUTI ...	Hillan Kenneth J.	Director	Grant	A	0.00	15,000	0	15,000	0 to 15 K
Jul 31 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Option Exercise	E	0.00	1	0	1
Jul 31 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Option Exercise	E	0.00	1	0	2
Jun 29 2020	SGMO	SANGAMO THERAPEUTI ...	McClung David Mark	EVP, Chief Business ...	Option Exercise	A	9.16	200,000	1,832,000	200,000
Jun 29 2020	SGMO	SANGAMO THERAPEUTI ...	McClung David Mark	EVP, Chief Business ...	Grant	A	0.00	100,000	0	100,000	0 to 100 K
Jun 05 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Option Exercise	M	2.09	1	2	2
Jun 05 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Sell	D	11.23	14,907	167,406	70,116	85 K to 70.1 K (-17.53 %)
Jun 05 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Buy	M	0.00	14,907	0	85,023	70.1 K to 85 K (+21.26 %)
Jun 05 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Option Exercise	M	2.09	1	2	2
Jun 05 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Sell	D	11.23	14,907	167,406	70,116	85 K to 70.1 K (-17.53 %)
Jun 05 2020	SGMO	SANGAMO THERAPEUTI ...	Boissel Stephane	EVP, Corp. Strategy	Buy	M	0.00	14,907	0	85,023	70.1 K to 85 K (+21.26 %)
May 20 2020	SGMO	SANGAMO THERAPEUTI ...	Zakrzewski Joseph S	Director	Option Exercise	A	10.46	15,000	156,900	15,000
May 20 2020	SGMO	SANGAMO THERAPEUTI ...	Zakrzewski Joseph S	Director	Grant	A	0.00	2,500	0	32,500	30 K to 32.5 K (+8.33 %)
May 20 2020	SGMO	SANGAMO THERAPEUTI ...	Smith Karen L.	Director	Option Exercise	A	10.46	15,000	156,900	15,000

View all SANGAMO THERAPEUTICS, INC insider transactions.